These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19070978

  • 1. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ, Wang B, Gao ZQ, Liu JG, Liu ZQ, Niu QL, Sun ZK, Yuan YX.
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [Abstract] [Full Text] [Related]

  • 2. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation.
    Wang XZ, Wang B, Gao ZQ, Liu JG, Liu ZQ, Niu QL, Sun ZK, Yuan YX.
    J Magn Reson Imaging; 2009 Jun; 29(6):1360-6. PubMed ID: 19472393
    [Abstract] [Full Text] [Related]

  • 3. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM.
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [Abstract] [Full Text] [Related]

  • 4. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A, Hricak H, Moskowitz C, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL.
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [Abstract] [Full Text] [Related]

  • 5. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H, Kizilgöz V, Tatar IG, Damar C, Ugan AR, Paker I, Hekimoğlu B.
    J Comput Assist Tomogr; 2012 Nov; 36(1):30-45. PubMed ID: 22261768
    [Abstract] [Full Text] [Related]

  • 6. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
    Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA.
    Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
    [Abstract] [Full Text] [Related]

  • 7. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
    Weis J, Ahlström H, Hlavcak P, Häggman M, Ortiz-Nieto F, Bergman A.
    Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
    [Abstract] [Full Text] [Related]

  • 8. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
    Ma C, Chen L, Scheenen TW, Lu J, Wang J.
    Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
    [Abstract] [Full Text] [Related]

  • 9. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ.
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [Abstract] [Full Text] [Related]

  • 10. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.
    Nagarajan R, Margolis D, Raman S, Sarma MK, Sheng K, King CR, Verma G, Sayre J, Reiter RE, Thomas MA.
    J Magn Reson Imaging; 2012 Sep; 36(3):697-703. PubMed ID: 22581787
    [Abstract] [Full Text] [Related]

  • 11. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P.
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [Abstract] [Full Text] [Related]

  • 12. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
    Nagarajan R, Gomez AM, Raman SS, Margolis DJ, McClure T, Thomas MA.
    NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
    [Abstract] [Full Text] [Related]

  • 13. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, Wright AJ, Barentsz JO, Heerschap A, Scheenen TW.
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [Abstract] [Full Text] [Related]

  • 14. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA, van der Graaf M, Engelbrecht MR, van Leenders GJ, Verhofstad A, Rijpkema M, de la Rosette JJ, Barentsz JO, Heerschap A.
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [Abstract] [Full Text] [Related]

  • 15. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
    Giusti S, Caramella D, Fruzzetti E, Lazzereschi M, Tognetti A, Bartolozzi C.
    Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851
    [Abstract] [Full Text] [Related]

  • 16. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
    Kumar V, Jagannathan NR, Kumar R, Das SC, Jindal L, Thulkar S, Gupta SD, Dwivedi SN, Roell S, Hemal AK, Gupta NP.
    Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
    [Abstract] [Full Text] [Related]

  • 17. MRI spectroscopy in screening of prostate cancer.
    Goeb K, Engehausen DG, Krause FS, Hollenbach HP, Niedobitek G, Buettner M, Frangou P, Engelhard K.
    Anticancer Res; 2007 Jun; 27(1B):687-93. PubMed ID: 17348461
    [Abstract] [Full Text] [Related]

  • 18. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, Zakian KL, Koutcher JA.
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [Abstract] [Full Text] [Related]

  • 19. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
    Stadlbauer A, Nimsky C, Buslei R, Pinker K, Gruber S, Hammen T, Buchfelder M, Ganslandt O.
    Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.